Al-Qawasmeh RA, Lee Y, Cao MY, Gu X, Viau S, Lightfoot J, Wright JA, Young AH. 11-Phenyl-[b,e]-dibenzazepine compounds: novel antitumor agents.
Bioorg Med Chem Lett 2008;
19:104-7. [PMID:
19027297 DOI:
10.1016/j.bmcl.2008.11.001]
[Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2008] [Revised: 10/31/2008] [Accepted: 11/03/2008] [Indexed: 11/26/2022]
Abstract
A series of 11-phenyl-[b,e]-dibenzazepine compounds were synthesized and shown to be inhibitors of tumor cell proliferation with IC(50) values ranging from submicromolar to micromolar concentrations. Flow cytometric analyses of several active compounds demonstrated inhibition of cell cycle progression at the G(0)-G(1) phase transition resulting in G(0)-G(1) arrest.
Collapse